About Yug Varma
Form D filings for Phi Therapeutics from 2019 to 2024 list Yug Varma as executive officer and director.
Yug Varma first appears on SEC filings in 2019.
Experience
This experience comes from SEC filings. The years are when the filings name Yug Varma in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Yug Varma works with at each company, as listed on that company's latest Form D.
Phi Therapeutics, Inc. · Form D/A, Jun 26, 2024